# Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer

> **NCT02856048** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 11 (actual)

## Conditions studied

- Cancer
- Toxicity Due to Chemotherapy
- Sarcoma
- Osteosarcoma
- Lymphoma
- Ewing Sarcoma

## Interventions

- **DRUG:** Triptorelin (GnRHa) + Chemotherapy

## Key facts

- **NCT ID:** NCT02856048
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11-23
- **Primary completion:** 2021-02
- **Final completion:** 2021-02
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02856048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02856048, "Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02856048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*